Skip to main content
SpringerLink
Log in

5-hydroxytryptamine content of glioma

  • Kurze Mitteilungen
  • Published:
Experientia Aims and scope Submit manuscript

Résumé

La teneur en 5-HT de tumeurs intra-crâniennes humaines, déterminée par une méthode biologique, est en général plus faible que celle du cortex cérébral adjacent. Cette observation n'est pas en faveur de l'hypothése que la 5-HT est localisée dans les cellules névroglies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. G. P. Lewis, J. Pharm. Lond.10, 529 (1958).

    Article  CAS  Google Scholar 

  2. P. Correale, J. Neurochem.1, 22 (1956).

    Article  CAS  Google Scholar 

  3. J. R. Vane, Brit. J. Pharmacol.12, 344 (1957).

    CAS  Google Scholar 

  4. D. Joyce, Brit. J. Pharmacol.18, 370 (1962).

    CAS  Google Scholar 

  5. T. J. Sullivan, Brit. J. Pharmacol.12, 344 (1961).

    Google Scholar 

  6. E. Bülbring, F. J. Philpot, andF. D. Bosanquet, Lancet I,1953, 865.

  7. J. D. P. Graham, Nature, Lond.183, 1733 (1959).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychology, Birkbeck College, London, Great Britain

    Daphne Joyce

Authors
  1. Daphne Joyce
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joyce, D. 5-hydroxytryptamine content of glioma. Experientia 19, 187–188 (1963). https://doi.org/10.1007/BF02172303

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02172303

Keywords

Search

Navigation